An experimental vaccine to protect against Ebola is safe, research has revealed.
The first trial of filovirus vaccines in Africa revealed the drug generated a similar immune response in healthy Ugandan adults, as those reported in American volunteers earlier this year.
|Disclaimer: Opinions expressed here are those of the writers and do not reflect those of Peacefmonline.com. Peacefmonline.com accepts no responsibility legal or otherwise for their accuracy of content. Please report any inappropriate content to us, and we will evaluate it as a matter of priority.|